JP2013544842A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013544842A5 JP2013544842A5 JP2013542143A JP2013542143A JP2013544842A5 JP 2013544842 A5 JP2013544842 A5 JP 2013544842A5 JP 2013542143 A JP2013542143 A JP 2013542143A JP 2013542143 A JP2013542143 A JP 2013542143A JP 2013544842 A5 JP2013544842 A5 JP 2013544842A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- alkyl
- alkenyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- HJPXILQMJHQFOX-UHFFFAOYSA-N CC(C)C(C1)C(C)C2C1C2C Chemical compound CC(C)C(C1)C(C)C2C1C2C HJPXILQMJHQFOX-UHFFFAOYSA-N 0.000 description 1
- BNYYSZJEZLQIFH-UHFFFAOYSA-N Cc(ccc(OCc1cccc(N)c1)c1)c1C(C(c1ccc(CC(O)=O)cc1C)=C)=O Chemical compound Cc(ccc(OCc1cccc(N)c1)c1)c1C(C(c1ccc(CC(O)=O)cc1C)=C)=O BNYYSZJEZLQIFH-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41911510P | 2010-12-02 | 2010-12-02 | |
| US61/419,115 | 2010-12-02 | ||
| PCT/US2011/062691 WO2012075174A2 (en) | 2010-12-02 | 2011-11-30 | Compounds and methods for skin repair |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013544842A JP2013544842A (ja) | 2013-12-19 |
| JP2013544842A5 true JP2013544842A5 (cg-RX-API-DMAC7.html) | 2015-01-29 |
Family
ID=45316123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013542143A Pending JP2013544842A (ja) | 2010-12-02 | 2011-11-30 | 皮膚修復のための化合物および方法 |
Country Status (16)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2013001866A (es) * | 2010-08-17 | 2013-05-22 | Allergan Inc | Agonistas de receptor de prostaglandina suptipo-2(ep2) o receptor de prostaglandina suptipo-4(ep4) para tratar la opacidad de la cornea |
| US8697057B2 (en) | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8900571B2 (en) * | 2010-08-19 | 2014-12-02 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8926963B2 (en) * | 2010-08-19 | 2015-01-06 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8894992B2 (en) * | 2010-08-19 | 2014-11-25 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8889123B2 (en) * | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US9005605B2 (en) * | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8883139B2 (en) * | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
| CA2890034A1 (en) * | 2012-11-16 | 2014-05-22 | Allergan, Inc. | Skin wound healing and scar reduction with prostaglandin ep4 agonist combinations |
| CA2891595A1 (en) * | 2012-11-16 | 2014-05-22 | Allergan, Inc. | Compounds and methods for skin repair |
| CA2924843A1 (en) * | 2013-09-27 | 2015-04-02 | Allergan, Inc. | Compounds and methods for skin repair |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811446A (en) * | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
| US5877211A (en) * | 1997-11-21 | 1999-03-02 | Allergan | EP2 receptor agonists as neuroprotective agents for the eye |
| TWI249520B (en) * | 1998-07-15 | 2006-02-21 | Ono Pharmaceutical Co | 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient |
| WO2000015608A1 (fr) * | 1998-09-14 | 2000-03-23 | Ono Pharmaceutical Co., Ltd. | Derives e de phenyl-prostaglandine a substitution-φ et medicaments les contenant comme ingredient actif |
| ES2289140T3 (es) * | 2001-07-16 | 2008-02-01 | F. Hoffmann-La Roche Ag | Derivados de 2-pirrolidona como agonistas de prostanoide. |
| TWI313608B (en) * | 2001-07-23 | 2009-08-21 | Ono Pharmaceutical Co | Lower bone mass treating agent containing er4 agonist as active ingredient |
| US20040058313A1 (en) * | 2002-04-24 | 2004-03-25 | Abreu Marcio Marc | Compositions, targets, methods and devices for the therapy of ocular and periocular disorders |
| PT2465537T (pt) * | 2002-10-10 | 2016-08-03 | Ono Pharmaceutical Co | Microsferas compreendendo ono-1301 |
| CN1735597A (zh) * | 2003-01-10 | 2006-02-15 | 霍夫曼-拉罗奇有限公司 | 作为前列腺素激动剂的2－哌啶酮衍生物 |
| US6875787B2 (en) | 2003-02-11 | 2005-04-05 | Allergan, Inc. | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| US7855226B2 (en) | 2003-02-11 | 2010-12-21 | Allergan, Inc. | Treatment of inflammatory bowel disease |
| WO2005027931A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an ep2 or ep4 selective agonist |
| WO2006137472A1 (ja) * | 2005-06-24 | 2006-12-28 | Taisho Pharmaceutical Co., Ltd. | プロスタグランジン誘導体 |
| US20070232660A1 (en) * | 2006-04-04 | 2007-10-04 | Allergan, Inc. | Therapeutic and delivery methods of prostaglandin ep4 agonists |
| US7439372B2 (en) * | 2006-05-03 | 2008-10-21 | Allergan, Inc. | Therapeutic compounds |
| EA015931B1 (ru) * | 2006-12-15 | 2011-12-30 | Глэксо Груп Лимитед | Бензамидные производные как агонисты ер-рецепторов |
| JP2010513551A (ja) * | 2006-12-18 | 2010-04-30 | アラーガン インコーポレイテッド | 胃腸疾患の治療方法および組成物 |
| WO2008092860A1 (en) * | 2007-01-30 | 2008-08-07 | Janssen Pharmaceutica N.V. | Bicyclic derivatives as ep4 agonists |
| WO2008092861A1 (en) * | 2007-01-30 | 2008-08-07 | Janssen Pharmaceutica N.V. | Bicyclic derivatives as ep4 agonists |
| WO2008092862A1 (en) * | 2007-01-30 | 2008-08-07 | Janssen Pharmaceutica N.V. | Bicyclic derivatives as ep4 agonists |
| GB0810615D0 (en) * | 2008-06-10 | 2008-07-16 | Glaxo Group Ltd | Novel pharmaceutical |
| US20110111031A1 (en) * | 2009-04-20 | 2011-05-12 | Guang-Liang Jiang | Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof |
| US20120136011A1 (en) * | 2010-07-30 | 2012-05-31 | Allergan, Inc. | Compounds and methods for skin repair |
| US8697056B2 (en) * | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
-
2011
- 2011-11-29 US US13/306,637 patent/US20120142684A1/en not_active Abandoned
- 2011-11-30 WO PCT/US2011/062691 patent/WO2012075174A2/en not_active Ceased
- 2011-11-30 AU AU2011336582A patent/AU2011336582A1/en not_active Abandoned
- 2011-11-30 MX MX2013006163A patent/MX2013006163A/es unknown
- 2011-11-30 KR KR1020137017027A patent/KR20130119958A/ko not_active Withdrawn
- 2011-11-30 CN CN2011800627436A patent/CN103282033A/zh active Pending
- 2011-11-30 CA CA2819471A patent/CA2819471A1/en not_active Abandoned
- 2011-11-30 BR BR112013015781A patent/BR112013015781A2/pt not_active Application Discontinuation
- 2011-11-30 JP JP2013542143A patent/JP2013544842A/ja active Pending
- 2011-11-30 EP EP16198852.2A patent/EP3195863A1/en not_active Withdrawn
- 2011-11-30 RU RU2013129262/15A patent/RU2013129262A/ru not_active Application Discontinuation
- 2011-11-30 SG SG2013042171A patent/SG190947A1/en unknown
- 2011-11-30 EP EP11794357.1A patent/EP2646017B1/en not_active Not-in-force
- 2011-12-02 TW TW100144475A patent/TW201307313A/zh unknown
- 2011-12-02 AR ARP110104524A patent/AR084144A1/es unknown
-
2013
- 2013-05-30 ZA ZA2013/03949A patent/ZA201303949B/en unknown
- 2013-05-31 CL CL2013001579A patent/CL2013001579A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013544842A5 (cg-RX-API-DMAC7.html) | ||
| JP2013536183A5 (cg-RX-API-DMAC7.html) | ||
| RU2013108394A (ru) | Соединения и способы восстановления кожи | |
| RU2013129262A (ru) | Соединения и способы для восстановления кожи | |
| RU2014113663A (ru) | Композиции кожного наполнителя для лечения мелких морщин | |
| JP2013517263A5 (cg-RX-API-DMAC7.html) | ||
| KR102292206B1 (ko) | 티로신 유도체 및 이를 포함하는 조성물 | |
| JP2017214429A5 (cg-RX-API-DMAC7.html) | ||
| KR20100098633A (ko) | 자색반병의 치료를 위한 조성물 및 방법 | |
| JP2016517431A5 (cg-RX-API-DMAC7.html) | ||
| RU2018106453A (ru) | Соединения | |
| RU2015116264A (ru) | Композиции и способы лечения сердечной недостаточности у пациентов с диабетом | |
| RU2012134065A (ru) | Альфа-2 адренергический агонист, обладающий эффектом длительного снижения внутриглазного давления | |
| JP2015528479A5 (cg-RX-API-DMAC7.html) | ||
| RU2014112324A (ru) | Применение органического соединения для лечения синдрома нунан | |
| JP2016514150A5 (cg-RX-API-DMAC7.html) | ||
| RU2014128387A (ru) | Ингибиторы рi3к для лечения фиброзных заболеваний | |
| JP2003528919A5 (cg-RX-API-DMAC7.html) | ||
| DK2004235T3 (da) | Sammensætning til kosmetisk eller farmaceutisk-dermatologisk anvendelse | |
| JP2015537028A5 (cg-RX-API-DMAC7.html) | ||
| JP2014517038A5 (cg-RX-API-DMAC7.html) | ||
| JP2015537028A (ja) | 皮膚修復のための組成物および方法 | |
| RU2014150946A (ru) | Способ снижения веса | |
| RU2014152196A (ru) | Способ улучшения функции печени | |
| JP2018534358A (ja) | Ｖｅｇｆ阻害剤の局所投与による皮膚障害の処置 |